Receptor for Macrophage Colony-stimulating Factor Transduces a Signal Decreasing Erythroid Potential in the Multipotent Hematopoietic EML Cell Line
Overview
Affiliations
Objective: To test the hypothesis that hematopoietic growth factors may influence lineage choice in pluripotent progenitor cells, we investigated the effects of macrophage colony-stimulating factor (M-CSF) on erythroid and myeloid potentials of multipotent EML cells ectopically expressing M-CSF receptor (M-CSFR).
Methods: EML cells are stem cell factor (SCF)-dependent murine cells that give rise spontaneously to pre-B cells, burst-forming unit erythroid (BFU-E), and colony-forming unit granulocyte macrophage (CFU-GM). We determined BFU-E and CFU-GM frequencies among EML cells transduced with murine M-CSFR, human M-CSFR, or chimeric receptors, and cultivated in the presence of SCF, M-CSF, or both growth factors. Effects of specific inhibitors of signaling molecules were investigated.
Results: EML cells transduced with murine M-CSFR proliferated in response to M-CSF but also exhibited a sharp and rapid decrease in BFU-E frequency associated with an increase in CFU-GM frequency. In contrast, EML cells expressing human M-CSFR proliferated in response to M-CSF without any changes in erythroid or myeloid potential. Using chimeric receptors between human and murine M-CSFR, we showed that the effects of M-CSF on EML cell differentiation potential are mediated by a large region in the intracellular domain of murine M-CSFR. Furthermore, phospholipase C (PLC) inhibitor U73122 interfered with the negative effects of ligand-activated murine M-CSFR on EML cell erythroid potential.
Conclusion: We propose that signaling pathways activated by tyrosine kinase receptors may regulate erythroid potential and commitment decisions in multipotent progenitor cells and that PLC may play a key role in this process.
The Making of Hematopoiesis: Developmental Ancestry and Environmental Nurture.
Brown G, Ceredig R, Tsapogas P Int J Mol Sci. 2018; 19(7).
PMID: 30037064 PMC: 6073875. DOI: 10.3390/ijms19072122.
Lost in translation: pluripotent stem cell-derived hematopoiesis.
Ackermann M, Liebhaber S, Klusmann J, Lachmann N EMBO Mol Med. 2015; 7(11):1388-402.
PMID: 26174486 PMC: 4644373. DOI: 10.15252/emmm.201505301.
Jing X, Infante J, Nachtman R, Jurecic R Exp Hematol. 2008; 36(9):1110-20.
PMID: 18495327 PMC: 2570181. DOI: 10.1016/j.exphem.2008.04.001.
Finstad S, Rosenberg N, Levy L J Virol. 2007; 81(13):7274-9.
PMID: 17428873 PMC: 1933319. DOI: 10.1128/JVI.00250-07.
Bourgin C, Bourette R, Arnaud S, Liu Y, Rohrschneider L, Mouchiroud G Mol Cell Biol. 2002; 22(11):3744-56.
PMID: 11997510 PMC: 133813. DOI: 10.1128/MCB.22.11.3744-3756.2002.